Document Detail


Soluble interleukin 2 receptor levels in children with type I insulin-dependent diabetes mellitus.
MedLine Citation:
PMID:  7762968     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Soluble interleukin 2 receptor (sIL-2R) levels reflect mononuclear cell activation and are elevated in a variety of autoimmune, neoplastic and infectious conditions. Several investigators have studied sIL-2R levels in patients with Type I diabetes mellitus (IDDM), but results have been conflicting. Our primary objective in this study was to compare sIL-2R levels of children and adolescents with newly diagnosed IDDM with those of age-matched controls. In addition, sIL-2R levels in a cohort of patients were followed longitudinally for 1 to 2 years after diagnosis. Serum sIL-2R levels of 38 IDDM children and adolescents (age < 20 years) were compared with levels of 39 nondiabetic, age-matched controls. Mean sIL-2R levels declined with age (P < 0.000005), and there was no significant difference in the regression line relating age and sIL-2R levels between patients and controls. The sIL-2R levels remained fairly consistent over 1-2 years of follow up. The presence of islet cell antibodies (ICA) had no apparent effect on sIL-2R levels in children with diabetes. The sIL-2R levels were similar in magnitude among first degree relatives of patients with IDDM compared to the range of unrelated subjects. It is our conclusion that sIL-2R levels are highest during infancy and decline throughout childhood. The sIL-2R levels do not appear to be clinically useful as a reflection of immune activation in patients with IDDM. Finally, there may be a genetic influence which partially regulates production of sIL-2R.
Authors:
L A Gartner; M C Pfeifer; C Albini; G L Francis
Related Documents :
9703338 - Enhanced responsiveness of blood pressure to sodium intake and to angiotensin ii is ass...
6680538 - Lipid disorders in thai diabetics.
15998278 - Effect of non-surgical periodontal treatment with or without doxycycline on the periodo...
9005968 - Do non-insulin-dependent diabetes mellitus (niddm) and insulin-dependent diabetes melli...
12165188 - Cordymax cs-4 improves glucose metabolism and increases insulin sensitivity in normal r...
22381908 - Emerging diabetes therapies and technologies.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Annals of clinical and laboratory science     Volume:  25     ISSN:  0091-7370     ISO Abbreviation:  Ann. Clin. Lab. Sci.     Publication Date:    1995 Jan-Feb
Date Detail:
Created Date:  1995-06-29     Completed Date:  1995-06-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0410247     Medline TA:  Ann Clin Lab Sci     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  44-51     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Autoantibodies / blood
Case-Control Studies
Child
Cohort Studies
Diabetes Mellitus, Type 1 / blood*
Female
Humans
Islets of Langerhans / immunology
Male
Matched-Pair Analysis
Receptors, Interleukin-2 / analysis*
Solubility
Chemical
Reg. No./Substance:
0/Autoantibodies; 0/Receptors, Interleukin-2; 0/islet cell antibody

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Infectious disease markers in various groups of donors.
Next Document:  Immunohistochemical analysis of P-glycoprotein expression in breast cancer: clinical correlations.